Non-small cell lung cancer (NSCLC) is the leading cause of cancer death in the United States (1). We mined published microarray data (2, 3, 4) to identify differentially expressed genes in NSCLC. We found that FXYD6 was among the genes whose expression was most quantitatively different in tumors from patients with NSCLC as compared to the lung. FXYD6 expression was significantly decreased in NSCLC tumors as compared to the lung, and lower expression of FXYD6 in patient tumors was significantly associated with worse overall survival. FXYD6 may be important for initiation or progression of non-small cell lung cancer in humans.